🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Human umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    mab active

    1 trial

  2. Hyaluronic Acid

    Hospital Authority, Hong Kong

    Shoulder Pain

    small molecule completed

    1 trial

  3. Hydrochloride anlotinib

    Zhongnan Hospital

    Uterine Cervical Neoplasms

    small molecule active

    1 trial

  4. Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin

    The First People's Hospital of Lianyungang

    Hypertension

    small molecule completed

    1 trial

  5. Hydrogen Peroxide 3 % Topical Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Warts

    small molecule active

    1 trial

  6. Hypofraction radiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other completed

    1 trial

  7. Hypofractionated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    other active

    1 trial

  8. IPT plus HD-tDCS

    The First People's Hospital of Lianyungang

    Depressive Disorder

    other active

    1 trial

  9. Ibuprofen

    United Therapeutics Europe Ltd

    Immune System and Related Disorders

    small molecule completed

    1 trial

  10. Immediate CEUS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    other active

    1 trial

  11. Immune-enhancing nutritional beverage

    United Therapeutics Europe Ltd

    Mitigation of Immune Function Decrements in Response to Stress

    other completed

    1 trial

  12. Immunohistochemistry or genetic test

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Glioma

    other active

    1 trial

  13. Immunosuppressive therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    In-stent Restenosis Lesion

    small molecule active

    1 trial

  14. Indomethacin and Ibuprofen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ductus Arteriosus, Patent

    small molecule terminated

    1 trial

  15. Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma (PCNSL)

    small molecule active

    1 trial

  16. Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

    The First People's Hospital of Lianyungang

    CD30+ Peripheral T-cell Lymphoma

    small molecule active

    1 trial

  17. Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

    Hospital Authority, Hong Kong

    CD30+ Peripheral T-cell Lymphoma

    small molecule active

    1 trial

  18. Inhaled Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ventilator-Associated Pneumonia (VAP)

    small molecule active

    1 trial

  19. Innovative Dietary Formulation (Patent ID: CN110250417A)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    other completed

    1 trial

  20. Intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial

  21. Intensive BP treatment group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    small molecule completed

    1 trial

  22. Intestinal Microbiota Transplant (IMT) Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiovascular Disease

    small molecule active

    1 trial

  23. Intranasal Oxytocin (OT) 24 IU

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Participants

    small molecule active

    1 trial

  24. Intraoperative identification method

    Xijing Hospital

    Thyroid Cancer

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources